600774.SH
汉商集团
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 7.17
−2.05%Margins
Gross margin
47.0%
EBITDA margin
-3.0%
EBIT margin
-17.2%
Net margin
-18.3%
FCF margin
10.7%
-12.4%
Return on equity
-5.6%
Return on assets
-8.0%
Return on invested capital
0.31x
Asset turnover
CNY 133.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026